Blog
RSS FeedPosted by Michael Wonder on 08 Mar 2018
CADTH Common Drug Review will accept submissions up to six months pre-Notice of Compliance
8 March 2018 - Operational change can help reduce the time between regulatory approval and reimbursement recommendations for prescription drugs ...
Posted by Michael Wonder on 16 Nov 2017
Industry fees are applicable to all CDR resubmissions
13 November 2017 - All resubmissions that are filed by manufacturers on or after 2 January 2018 will be subject to ...
Posted by Michael Wonder on 15 Nov 2017
Revised procedure for the CADTH Common Drug Review resubmissions
13 November 2017 - In August 2017, CADTH invited stakeholder comments and feedback on a proposal to revise the resubmission requirements ...
Posted by Michael Wonder on 15 Aug 2017
Posting of key milestones for CDR projects
14 August 2017 - Key milestones for CDR submissions, resubmissions, and requests for advice will now be posted within the ...
Posted by Michael Wonder on 01 Aug 2017
Sharing patient input submissions for the CDR program
1 August 2017 - Since February 2014, CADTH has shared patient input submissions on our website, when permission has been ...
Posted by Michael Wonder on 28 Mar 2017
Roche withdraws submission for Avastin
28 March 2017 - Roche was seeking a positive CADTH recommendation for the use of bevacizumab in combination with pemetrexed ...
Posted by Michael Wonder on 25 Nov 2016
CADTH calls for input on submission for new medicine for patients with biliary cirrhosis
24 November 2016 - CADTH is calling for patient input on a pending submission from Intercept Pharmaceuticals for obeticholic acid. ...
Posted by Michael Wonder on 18 Oct 2016
CADTH calls for patient input on a submission for Zinbryta (daclizumab)
18 October 2016 - CADTH is calling for patient input on Biogen's submission for Zinbryta (daclizumab). ...
Posted by Michael Wonder on 12 Oct 2016
CADTH calls for patient input on submission from Servier for Corlovan
11 October - CADTH is calling for patient input on a submission from Servier for Corlovan (ivabradine hydrochloride). ...
Posted by Michael Wonder on 07 Oct 2016
CADTH calls for patient input on a submission from Celopharma for Mifegymiso
6 October 2016 - CADTH is calling for patient input on a submission from Celopharma for its combination product Mifegymiso. ...
Posted by Michael Wonder on 04 Oct 2016
Abortion-drug company open to restarting reimbursement review process
27 September 2016 - The company that is bringing the gold standard in abortion drugs to Canada says it is “open” ...
Posted by Michael Wonder on 22 Sep 2016
CADTH calls for patient input on a resubmission from NovoNordisk for Victoza (liraglutide)
21 September 2016 - CADTH is calling for patient input on a resubmission from Novo Nordisk for Victoza (liraglutide). ...
Posted by Michael Wonder on 13 Sep 2016
CADTH calls for patient input on submission from Sanofi for sarilumab
13 September 2016 - CADTH is calling for patient input on Sanofi Genzyme's new interleukin 6 receptor antagonist. ...
Posted by Michael Wonder on 11 Sep 2016
CADTH calls for patient input on submission from Duchesnay for Mictoryl (propiverine hydrochloride)
9 February 2016 - CADTH is seeking patient input on a submission from Duchesnay for Mictoryl. ...
Posted by Michael Wonder on 12 Aug 2016
CADTH calls for patient input on submission from Janssen for Stelara (ustekinumab)
12 August 2016 - CADTH has received notice of a pending submission from Janssen for ustekinumab for use by patients with ...